{
  "id": 20702239,
  "title": "Amplia gets nod for new cancer drug trial ahead of US push",
  "url": "https://urgent.news/2026/11/19/amplia-gets-nod-for-new-cancer-drug-trial-ahead-of-us-push-20702239",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-19T03:44:31.000Z",
  "source": {
    "name": "The Age",
    "slug": "the-age",
    "url": "https://www.theage.com.au/business/companies/amplia-gets-nod-for-new-cancer-drug-trial-ahead-of-us-push-20261119-p61fo7.html?ref=rss"
  },
  "original_language": "en",
  "account": null,
  "summary": "Amplia Therapeutics has received ethics approval for its ACCENT-Mini pancreatic cancer trial, paving the way to test daily doses of its narmafotinib drug alongside chemotherapy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Sydney Morning Herald",
        "title": "Amplia gets nod for new cancer drug trial ahead of US push",
        "url": "https://urgent.news/2026/11/19/amplia-gets-nod-for-new-cancer-drug-trial-ahead-of-us-push",
        "published": "2026-11-19T03:44:31.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}